https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2022.946060/full
Frontiers | Evaluation and multi-institutional validation of a novel urine biomarker lncRNA546 to...
Background and objectives. Prostate specific antigen (PSA) is currently the most commonly used biomarker for prostate cancer diagnosis. However, when PSA is ...